greeksoup/ stock research

Dolby Laboratories (DLB) FY2016 results: revenue $1.0 billion, up 5.7% on the year

Dolby Laboratories, Inc. (DLB) reported revenue of $1.0 billion for fiscal 2016, the year ended 30 September 2016, up 5.7% on the year before. Net income was $186 million, up 2.5%, and diluted earnings per share $1.81. The figures are the company's own, from the 10-K it filed with the SEC on 18 November 2016.

Revenue
$1.0 billion
+5.7% on the year
FY2009FY2016
Operating margin
22.6%
22.0% a year earlier
FY2009FY2016
Net income
$186 million
+2.5% on the year
FY2009FY2016
Diluted EPS
$1.81
+3.4% on the year
FY2009FY2016

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2016FY2015FY2014On the yearLast 8 years
Revenue1,026971960+5.7%
Cost of revenue10994.870.2+14.9%
Gross profit917876890+4.7%
Gross margin89.4%90.2%92.7%
Research and development220201183+9.1%
Operating income232213274+8.7%
Operating margin22.6%22.0%28.5%
Interest expense0.10.2-0.2-31.7%
Pre-tax income236246276-4.0%
Income tax49.562.567.4-20.8%
Effective tax rate21.0%25.4%24.4%
Net income186181206+2.5%
Net margin18.1%18.7%21.5%
Diluted EPS$1.81$1.75$1.99+3.4%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2016FY2015FY2014On the yearLast 8 years
Operating cash flow360309362+16.4%
Capital expenditure10115875.4-36.0%
Free cash flow259152286+70.8%
Free cash flow margin25.3%15.6%29.8%
Cash from investing-282-204-205
Cash from financing-92.0-139-40.6
Depreciation and amortisation85.269.153.3+23.2%
Share-based compensation67.067.165.7-0.1%
Buybacks10110756.0-6.1%
Dividends paid48.441.00.0+18.0%
Dividend per share$0.50$0.42$0.00+19.0%
Diluted shares, weighted102m104m104m-1.4%

Balance sheet

$ millionFY2016FY2015FY2014On the yearLast 8 years
Shareholders' equity1,9701,8071,710+9.0%
Non-controlling interest8.58.921.6-5.1%
Debt0.00.00.0
Other liabilities331317252+4.4%
Total liabilities and equity2,3102,1331,984+8.3%
Fixed assets444403290+10.1%
Goodwill310308278+0.6%
Intangible assets21512863.7+68.9%
Investments516460528+12.1%
Cash and equivalents520532568-2.3%
Receivables75.710286.2-25.5%
Inventory16.413.98.5+17.9%
Other assets214188162+14.1%
Total assets2,3102,1331,984+8.3%

10-K for the year ended 30 September 2016, filed 18 November 2016: the filing.